Health Canada inspection
Shenzhen Haibin Pharmaceutical Co. Ltd: Health Canada inspection of Oct 17, 2023
Health Canada · GMP · rating C
Key facts
| Establishment | Shenzhen Haibin Pharmaceutical Co. Ltd |
|---|---|
| City | Shenzhen, Yantian District |
| Province | Guangdong |
| Country | China |
| Program | GMP |
| Start date | Oct 11, 2023 |
| End date | Oct 17, 2023 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.